Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.

Triplett TA, Garrison KC, Marshall N, Donkor M, Blazeck J, Lamb C, Qerqez A, Dekker JD, Tanno Y, Lu WC, Karamitros CS, Ford K, Tan B, Zhang XM, McGovern K, Coma S, Kumada Y, Yamany MS, Sentandreu E, Fromm G, Tiziani S, Schreiber TH, Manfredi M, Ehrlich LIR, Stone E, Georgiou G.

Nat Biotechnol. 2018 Sep;36(8):758-764. doi: 10.1038/nbt.4180. Epub 2018 Jul 16.

2.

Developmental regulation of myeloerythroid progenitor function by the Lin28b-let-7-Hmga2 axis.

Rowe RG, Wang LD, Coma S, Han A, Mathieu R, Pearson DS, Ross S, Sousa P, Nguyen PT, Rodriguez A, Wagers AJ, Daley GQ.

J Exp Med. 2016 Jul 25;213(8):1497-512. doi: 10.1084/jem.20151912. Epub 2016 Jul 11.

3.

Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo.

Nakayama H, Bruneau S, Kochupurakkal N, Coma S, Briscoe DM, Klagsbrun M.

Sci Rep. 2015 Jul 9;5:11789. doi: 10.1038/srep11789.

4.

AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation.

Boscolo E, Coma S, Luks VL, Greene AK, Klagsbrun M, Warman ML, Bischoff J.

Angiogenesis. 2015 Apr;18(2):151-62. doi: 10.1007/s10456-014-9453-2. Epub 2014 Nov 26.

5.

Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody.

Hernández JL, Padilla L, Dakhel S, Coll T, Hervas R, Adan J, Masa M, Mitjans F, Martinez JM, Coma S, Rodríguez L, Noé V, Ciudad CJ, Blasco F, Messeguer R.

PLoS One. 2013 Sep 4;8(9):e72480. doi: 10.1371/journal.pone.0072480. eCollection 2013.

6.

GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Coma S, Allard-Ratick M, Akino T, van Meeteren LA, Mammoto A, Klagsbrun M.

Angiogenesis. 2013 Oct;16(4):939-52. doi: 10.1007/s10456-013-9370-9. Epub 2013 Jul 28.

7.

Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein.

Shimizu A, Nakayama H, Wang P, König C, Akino T, Sandlund J, Coma S, Italiano JE Jr, Mammoto A, Bielenberg DR, Klagsbrun M.

J Biol Chem. 2013 Jan 25;288(4):2210-22. doi: 10.1074/jbc.M112.397398. Epub 2012 Nov 29.

9.

Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, Klagsbrun M.

Cancer Res. 2010 May 1;70(9):3823-32. doi: 10.1158/0008-5472.CAN-09-3048. Epub 2010 Apr 13.

10.

Polypurine hairpins directed against the template strand of DNA knock down the expression of mammalian genes.

de Almagro MC, Coma S, Noé V, Ciudad CJ.

J Biol Chem. 2009 Apr 24;284(17):11579-89. doi: 10.1074/jbc.M900981200. Epub 2009 Mar 3.

11.

Strand displacement of double-stranded DNA by triplex-forming antiparallel purine-hairpins.

Coma S, Noé V, Eritja R, Ciudad CJ.

Oligonucleotides. 2005 Dec;15(4):269-83.

PMID:
16396621
12.

Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J, Ciudad CJ.

Oligonucleotides. 2004;14(2):100-13.

PMID:
15294074
13.

Supplemental Content

Support Center